Literature DB >> 23938608

The risk of uterine malignancy is linearly associated with body mass index in a cohort of US women.

Kristy K Ward1, Angelica M Roncancio, Nina R Shah, Mitzie-Ann Davis, Cheryl C Saenz, Michael T McHale, Steven C Plaxe.   

Abstract

OBJECTIVE: We sought to quantify the relationship of uterine malignancy with body mass index (BMI). STUDY
DESIGN: The University HealthSystem Consortium database was queried to identify all women undergoing total hysterectomy with a recorded BMI in the overweight and obese categories. Least squares regression was applied to evaluate the association between increasing BMI and the proportion of women with a diagnosis of uterine malignancy. Multivariate binary logistic regression was performed to adjust for other known risk factors including age, race, and other comorbidities.
RESULTS: There were 6905 women who met inclusion criteria; 1891 (27.4%) of these had uterine malignancy. There is a linear relationship (y = 0.015x - 0.23, R(2) = 0.92) of the probability of uterine malignancy vs BMI. After adjusting for other risk factors, we found that each 1-U increase in BMI was significantly, independently associated with an 11% increase in the proportion of patients diagnosed with uterine malignancy (odds ratio, 1.11; 95% confidence interval, 1.09-1.13; P < .001).
CONCLUSION: In a population of women undergoing hysterectomy, we observed a linear increase in the frequency of uterine cancer associated with increasing BMI. This finding suggests that even relatively modest weight gain may significantly raise cancer risk. In the United States, the mean BMI for women is 26.5 kg/m(2) and it is estimated that more than half of US women have a BMI within the study's range. Our results could, therefore, be relevant to a majority of the population. The findings could increase popular acceptance of weight management as a key component of general health maintenance and, possibly, as an additional approach to cancer risk reduction.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  cancer risk; endometrial cancer; obesity; overweight

Mesh:

Year:  2013        PMID: 23938608     DOI: 10.1016/j.ajog.2013.08.007

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Does Obesity Affect Pathologic Agreement of Initial and Final Tumor Grade of Disease in Endometrial Cancer Patients?

Authors:  Laura R Daily; Jonathan D Boone; Hannah C Machemehl; Eric D Thomas; Gerald McGwin; J Michael Straughn; Charles A Leath
Journal:  Int J Gynecol Cancer       Date:  2017-05       Impact factor: 3.437

2.  Endometrial cancer survivors' sleep patterns before and after a physical activity intervention: A retrospective cohort analysis.

Authors:  Shannon D Armbruster; Jaejoon Song; Leticia Gatus; Karen H Lu; Karen M Basen-Engquist
Journal:  Gynecol Oncol       Date:  2018-02-01       Impact factor: 5.482

3.  Sexual health of endometrial cancer survivors before and after a physical activity intervention: A retrospective cohort analysis.

Authors:  Shannon D Armbruster; Jaejoon Song; Andrea Bradford; Cindy L Carmack; Karen H Lu; Karen M Basen-Engquist
Journal:  Gynecol Oncol       Date:  2016-09-24       Impact factor: 5.482

4.  Thickness of preperitoneal fat as a predictor of malignancy in overweight and obese women with endometrial polyps.

Authors:  Andrea Ciavattini; Jacopo DI Giuseppe; Nicolò Clemente; Lorenzo Moriconi; Giovanni Delli Carpini; Nina Montik; Laura Mazzanti
Journal:  Oncol Lett       Date:  2016-02-04       Impact factor: 2.967

5.  Body Size, Metabolic Factors, and Risk of Endometrial Cancer in Black Women.

Authors:  Todd R Sponholtz; Julie R Palmer; Lynn Rosenberg; Elizabeth E Hatch; Lucile L Adams-Campbell; Lauren A Wise
Journal:  Am J Epidemiol       Date:  2016-01-27       Impact factor: 4.897

6.  Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer.

Authors:  Motoko Kanno; Mayu Yunokawa; Makoto Nakabayashi; Makiko Omi; Ai Ikki; Megumi Mizusaki; Mai Nishimura; Yusuke Shimizu; Kota Okamoto; Yuji Tanaka; Atsushi Fusegi; Sachiho Netsu; Tomoko Kurita; Yoichi Aoki; Terumi Tanigawa; Maki Matoda; Sanshiro Okamoto; Hidetaka Nomura; Kohei Omatsu; Yuko Sugiyama; Kuniko Utsugi; Nobuhiro Takeshima; Hiroyuki Kanao
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

7.  Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity.

Authors:  Oleksandr Savcheniuk; Nazarii Kobyliak; Maryana Kondro; Oleksandr Virchenko; Tetyana Falalyeyeva; Tetyana Beregova
Journal:  BMC Complement Altern Med       Date:  2014-07-16       Impact factor: 3.659

8.  Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer.

Authors:  Günter Emons; Eric Steiner; Dirk Vordermark; Christoph Uleer; Nina Bock; Kerstin Paradies; Olaf Ortmann; Stefan Aretz; Peter Mallmann; Christian Kurzeder; Volker Hagen; Birgitt van Oorschot; Stefan Höcht; Petra Feyer; Gerlinde Egerer; Michael Friedrich; Wolfgang Cremer; Franz-Josef Prott; Lars-Christian Horn; Heinrich Prömpeler; Jan Langrehr; Steffen Leinung; Matthias W Beckmann; Rainer Kimmig; Anne Letsch; Michael Reinhardt; Bernd Alt-Epping; Ludwig Kiesel; Jan Menke; Marion Gebhardt; Verena Steinke-Lange; Nils Rahner; Werner Lichtenegger; Alain Zeimet; Volker Hanf; Joachim Weis; Michael Mueller; Ulla Henscher; Rita K Schmutzler; Alfons Meindl; Felix Hilpert; Joan Elisabeth Panke; Vratislav Strnad; Christiane Niehues; Timm Dauelsberg; Peter Niehoff; Doris Mayr; Dieter Grab; Michael Kreißl; Ralf Witteler; Annemarie Schorsch; Alexander Mustea; Edgar Petru; Jutta Hübner; Anne Derke Rose; Edward Wight; Reina Tholen; Gerd J Bauerschmitz; Markus Fleisch; Ingolf Juhasz-Boess; Lax Sigurd; Ingo Runnebaum; Clemens Tempfer; Monika J Nothacker; Susanne Blödt; Markus Follmann; Thomas Langer; Heike Raatz; Simone Wesselmann; Saskia Erdogan
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-10-19       Impact factor: 2.915

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.